Margaret Anushka Paul

Margaret Anushka Paul, Ph.D, has a diverse work experience spanning various roles in the pharmaceutical and healthcare industry.

Margaret Anushka currently works at Haleon as the Wellness Innovation Safety Lead, a position they started in January 2023. Prior to this, they served as the Pain Innovation Safety Lead from June to December 2022.

From 2013 to 2022, Margaret worked at GSK, where they held several positions. Notably, they were the RX-OTC Switch Safety Lead from May 2018 to June 2022. Margaret Anushka also served as the GSK CH - Pfizer CH integration SERM workstream lead from March 2020 to March 2021. Other roles at GSK included Skin Health Innovation Safety Lead, Manager Pharmacovigilance/Safety Evaluation and Risk Management, and Safety Evaluation Risk Management Scientist.

Before joining GSK, Margaret worked at Indegene Lifesystems Pvt. Ltd. from 2011 to 2013, where they held the roles of Account Director and Manager Client Services - Europe.

In 2010, Margaret had a traineeship at the European Medicines Agency, focusing on Medicines Regulation.

Prior to that, they worked at Resolute Communications as a Healthcare PR and Communications Account Executive from January to June 2007. Here, they were involved in product launches and press liaison.

In 2006, Margaret worked at Medicom Group as a Medical Education Account Executive, managing projects for Pfizer and Merck Pharmaceuticals, including coordinating advisory boards and building client relationships.

Margaret Anushka started their career in the healthcare industry with an internship at Ketchum in 2005, where they assisted in coordinating meetings and conducted research.

Overall, Margaret Anushka Paul, Ph.D, has accumulated extensive experience in various roles within the pharmaceutical and healthcare sector, demonstrating their expertise and adaptability in the industry.

Margaret Anushka Paul Ph.D has a comprehensive education history. Margaret Anushka obtained their Doctor of Philosophy (PhD) in Cardiovascular Medicine Research from King's College London from 2007 to 2011. Margaret Anushka pursued a Master of Science (MSc) with Merit in Biomedical Sciences Research (Cardiovascular Biology) at King's College London from 2004 to 2005. Margaret completed their Bachelor of Science (BSc) in Biological Sciences (Physiology) from the University of Leicester from 2000 to 2003. Additionally, they received a Certificate in Pharmacovigilance and Pharmacoepidemiology from the London School of Hygiene and Tropical Medicine, U. of London in 2014 to 2015. Before their tertiary education, they completed their secondary education at Colombo International School, where they studied various subjects for their London GCE O'level and A'level, including math, physics, chemistry, and biology.